301211.SZ
亨迪药业
SZSE · Healthcare · C 制造业 · CN
CNY 11.75
−5.77%Aug 24, 2026, 08:22 UTC
Hendi Pharmaceutical announced its 2026 half-year results: net profit attributable to shareholders was 30.1361 million yuan, up 62.48% year-on-year.
Source:
SZSE · Healthcare · C 制造业 · CN
Aug 24, 2026, 08:22 UTC